Last verified:

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) vs COUR Pharma

A detailed comparison to help you choose between Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) and COUR Pharmafor your Biopharmaceuticals needs.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

arcutis.com

Innovative biotherapeutics company focused on medical dermatology.

Key features (5)

  • Once-daily application
  • Steroid-free formulation
  • Indicated for plaque psoriasis
  • Indicated for atopic dermatitis
  • Patient assistance programs

Integrations (0)

View Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) Profile

COUR Pharma

courpharma.com

COUR Pharma develops targeted therapies to reprogram the immune system for autoimmune disease treatment.

Key features (5)

  • Antigen-specific treatment approach
  • Targeting a wide range of immune-mediated diseases
  • Focus on restoring normal immune function
  • Pipeline of next-generation therapies
  • Commitment to patient access and safety

Integrations (0)

View COUR Pharma Profile

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) Alternatives →

See more options like Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

COUR Pharma Alternatives →

See more options like COUR Pharma